Video Feature Proton Therapy










Allergy & Immunology

Cancer

Careers

Children’s Health

Diet & Nutrition

Endowments & Grants

Environment

Geriatrics

Heart Disease

Infectious Diseases

Men’s Health

Public Health

Psychiatry

Research

Substance Abuse

Vascular Disease

Wall of Laureates

Women’s Health


Noticias En Espanol








Introduccion

   Seguro Social



Medical Specialties

(Featured Sites)


Allergy & Immunology

Anesthesia

Cardiovascular Disease

Dermatology

Emergency Medicine

Endocrinology and

     Metabolism

Family Practice

Gastroenterology

General Practice

Geriatric Medicine

Gynecology

Gynecologic Oncology

Hematology

Infectious Diseases

Internal Medicine

Neonatology

Nephrology

Neurology

Neurological Surgery

Obstetrics and

     Gynecology

Oncology

Ophthalmology

Orthopedic Surgery

Otorhinolaryngology

Pathology

Pediatrics

Physical Medicine and

     Rehabilitation

Plastic Surgery

Podiatric Medicine

Preventative Medicine

Psychiatry 1 | 2 | 3 | 4 | 5

Pulmonary Disease

Radiology, Diagnostic

Radiology, Interventional

Radiology, Nuclear

Radiation Oncology

Rheumatology

Sports Medicine

Surgery, General

Surgery, Hand

Surgery, Thoracic

Surgery, Vascular

Surgery, Colon and

     Rectal

Surgery, Urology





























































Home | Contact | Disclaimer | Tour | Links Exchange

TeleMed International HQ, Inc. | Medical Standard Systems Corporation

Copyrights 1994- 2017 All Rights Reserved


Disclaimer: The opinions expressed by governmental institutions, authorities, scholars, academicians, researchers, educational institutions, pharmaceutical organizations, advertisers, individuals, blogs, websites, and links featured at HcVN are their own. They may not reflect or parallel our own thoughts and should not be taken as an endorsement.  With regards to your health related issues traditional or integrated, please consult your physicians.











 
Contacthttp://www.hcvn.com/HcVNNewWeb/Contact1/index.html

Login

Register




Typical Pediatric Proton Treatment Dayhttp://www.hcvn.com/HcVNNewWeb/HcVN%20News%20HcVNNewWeb/Video/A%20Typical%20Pediatric%20Proton%20Therapy%20Treatment%20Dayhttp://www.hcvn.com/HcVNNewWeb/HcVN%20News%20HcVNNewWeb/Video/A%20Typical%20Pediatric%20Proton%20Therapy%20Treatment%20Dayhttp://www.hcvn.com/HcVNNewWeb/HcVN%20News%20HcVNNewWeb/Video/A%20Typical%20Pediatric%20Proton%20Therapy%20Treatment%20Dayhttp://www.hcvn.com/HcVNNewWeb/HcVN%20News%20HcVNNewWeb/Video/A%20Typical%20Pediatric%20Proton%20Therapy%20Treatment%20Dayshapeimage_5_link_0shapeimage_5_link_1shapeimage_5_link_2



Comparison Proton Therapy & X-rayshttp://www.hcvn.com/HcVNNewWeb/HcVN%20News%20HcVNNewWeb/Video/Comparison%20Proton%20Therapy%20And%20Xrays



Proton Treatment Processhttp://www.hcvn.com/HcVNNewWeb/HcVN%20News%20HcVNNewWeb/Video/Proton%20Treatment%20Process



Conditions Treated By Proton Therapyhttp://www.hcvn.com/HcVNNewWeb/HcVN%20News%20HcVNNewWeb/Video/Conditions%20Treated%20By%20Proton%20Therapy



Proton Therapy Advantageshttp://www.hcvn.com/HcVNNewWeb/HcVN%20News%20HcVNNewWeb/Video/Proton%20Therapy%20Advantages



Proton Therapy Success Storieshttp://www.hcvn.com/HcVNNewWeb/HcVN%20News%20HcVNNewWeb/Video/Proton%20Therapy%20Success%20Stories



About Proton Therapyhttp://www.hcvn.com/HcVNNewWeb/HcVN%20News%20HcVNNewWeb/Video/About%20Proton%20Therapy



What Is Proton Therapyhttp://www.hcvn.com/HcVNNewWeb/HcVN%20News%20HcVNNewWeb/Video/What%20is%20Proton%20Therapy



Proton Research & Treatment Centerhttp://www.hcvn.com/HcVNNewWeb/HcVN%20News%20HcVNNewWeb/Video/Proton%20Research%20&%20Treatment%20Center

An unexpected player in a cancer defense system


Sweden - 28 November 2011 - Researchers of Karolinska Institutet and the University of Cologne, Germany, have identified a new protein involved in a defense mechanism against cancer. The VCP/p97 complex is best known for its role in protein destruction and is involved in a type of familial dementia and ALS. In a novel study the researchers now describe how this complex also plays an important role in regulating the recruitment of the tumor suppressor protein 53BP1 to damaged DNA - suggesting an important role for VCP/p97 in our body's defense against cancer.


Damage of DNA is potentially very dangerous and linked to the development of cancer. Since DNA damage is unavoidable, our cells are equipped with a sophisticated defense system that activates repair mechanisms. This process is initiated by binding of sensor proteins to the damaged DNA that in turn bind and activate other proteins responsible for repairing the damage. During the last decade, it has become clear how many of those proteins are recruited to the damaged DNA, but the mechanism by which the tumor suppressor 53BP1 finds its way has been puzzling.


The surprising finding of this study, presented in the

Nico Dantuma

Photo: Ulf Sirborn

scientific journal Nature Structural & Molecular Biology, is not only the identity of the new player but also how it is doing the job. By following proteins in cells with DNA damage, the researchers found that the VCP/p97 complex is among the proteins that are being recruited to DNA damage. This was unanticipated since VCP/p97 is known to be primarily involved in the destruction of defective proteins. VCP/p97 is doing this by unwinding them so that the waste proteins can be chopped in pieces by dedicated enzymes. This important function also explains its involvement in a type of familial dementia and ALS since this kind of waste proteins typically pile up in these diseases.


It turns out that VCP/p97 is doing something similar at damaged DNA although with a very different outcome. The work shows that VCP/p97 facilitates the binding of 53BP1 by removing a protein that occupies the places where 53BP1 can bind. So instead of unwinding a protein to prepare it for destruction, VCP/p97 pulls a protein out of the way for 53BP1. The researchers also show that worms that have less of this complex are very sensitive to DNA damage supporting an important and evolutionary conserved role of VCP/p97 in DNA damage control. This new mechanism of recruiting a protein by removing another one that gets in the way sheds new light onto how the tumor suppressor 53BP1 finds damaged DNA. An important question that remains is if VCP/p97 plays similar roles in other processes.

Publication:


References:

The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks


Klara Acs, S. Martijn Luijsterburg, Leena Ackermann, Florian A. Salomons, Thorsten Hoppe & Nico P. Dantuma


Nature Structural & Molecular Biology, online November 27 201, DOI: 10.1038/10.1038/nsmb.2188

  1. Journal website www.nature.com


Source: Karolinska Institute


 

Cancer

International News:    Asia    Africa    Europe    Latin America/Caribbean    Middle East